Breaking News Instant updates and real-time market news.

ABCM

Abcam

$20.87 /

-0.16 (-0.76%)

07:21
09/13/21
09/13
07:21
09/13/21
07:21

Abcam reports 2H adjusted EPS 4.8p vs. 3.6p last year

Reports 2H revenue GBP 150.2M vs. GBP 121.8M last year. Commenting on the performance, Alan Hirzel, Abcam's CEO, said: "Our team is dedicated to supporting life science discovery and the translation of discovery to social impact. Our financial performance, including 29% revenue growth, is one indicator of the trust the market has in our team, our innovation, and our brand. I am grateful to everyone at Abcam and our customers for their brilliant collaboration and efforts through this most challenging time. I thank our customers and partners for their continued support." "As I look ahead, I am convinced more than ever that we can extend our market leadership, sustain durable growth, and become an increasingly influential partner within our industry."

  • 13

    Sep

  • 22

    Oct

ABCM Abcam
$20.87 /

-0.16 (-0.76%)

06/24/21 Berenberg
Abcam price target raised to 1,350 GBp from 1,300 GBp at Berenberg
03/12/21 Berenberg
Abcam price target raised to 1,300 GBp from 1,180 GBp at Berenberg
03/09/21 JPMorgan
Abcam price target lowered to 1,300 GBp from 1,400 GBp at JPMorgan
03/09/21 RBC Capital
Abcam price target lowered to 1,640 GBp from 1,750 GBp at RBC Capital

TODAY'S FREE FLY STORIES

Conference/Events
Citi Trends management to meet with Benchmark » 10:39
10/18/21
10/18
10:39
10/18/21
10:39
CTRN

Citi Trends

$72.57 /

+2.67 (+3.82%)

Meeting to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTRN Citi Trends
$72.57 /

+2.67 (+3.82%)

CTRN Citi Trends
$72.57 /

+2.67 (+3.82%)

09/21/21 Benchmark
Citi Trends initiated with a Buy at Benchmark
08/25/21 Craig-Hallum
Citi Trends price target raised to $165 from $150 at Craig-Hallum
05/26/21 Craig-Hallum
Citi Trends price target raised to $150 from $142 at Craig-Hallum
04/15/21 Craig-Hallum
Citi Trends price target raised to $142 from $125 at Craig-Hallum
CTRN Citi Trends
$72.57 /

+2.67 (+3.82%)

Hot Stocks
EMA starts evaluating Pfizer/BioNTech COVID vaccine use in kids aged 5 to 11 » 10:38
10/18/21
10/18
10:38
10/18/21
10:38
PFE

Pfizer

$41.39 /

-0.1 (-0.24%)

, BNTX

BioNTech

$251.69 /

+3.93 (+1.59%)

The EMA announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

BNTX BioNTech
$251.69 /

+3.93 (+1.59%)

PFE Pfizer
$41.39 /

-0.1 (-0.24%)

Hot Stocks
EMA approves new manufacturing sites, new formulation for Pfizer/BioNTech shot » 10:35
10/18/21
10/18
10:35
10/18/21
10:35
PFE

Pfizer

$41.40 /

-0.09 (-0.22%)

, BNTX

BioNTech

$252.00 /

+4.24 (+1.71%)

The EMA announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

10/15/21 H.C. Wainwright
H.C. Wainwright ups Codexis target, says Pfizer pact may be growth driver
10/14/21 Craig-Hallum
Craig-Hallum keeps Buy rating on Codexis after today's curve ball'
10/14/21 Stifel
Codexis' large order being from Pfizer, not Merck, a 'plot twist,' says Stifel
10/12/21 Morgan Stanley
Pfizer price target raised to $48 from $45 at Morgan Stanley
BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

10/06/21 Jefferies
BioNTech initiated with a Hold at Jefferies
09/24/21 Morgan Stanley
Morgan Stanley says CDC call 'modest narrowing' of Pfizer booster recommendation
09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
08/27/21 UBS
BioNTech price target raised to $300 from $111 at UBS
PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

BNTX BioNTech
$252.00 /

+4.24 (+1.71%)

PFE Pfizer
$41.40 /

-0.09 (-0.22%)

Options
SoFi Technologies call volume above normal and directionally bullish » 10:25
10/18/21
10/18
10:25
10/18/21
10:25
SOFI

SoFi Technologies

$20.16 /

+0.78 (+4.02%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SOFI SoFi Technologies
$20.16 /

+0.78 (+4.02%)

SOFI SoFi Technologies
$20.16 /

+0.78 (+4.02%)

10/11/21 Morgan Stanley
SoFi Technologies initiated with an Overweight at Morgan Stanley
09/22/21
Fly Intel: Top five analyst initiations
09/22/21 Jefferies
SoFi Technologies initiated with a Buy at Jefferies
09/14/21 Mizuho
Mizuho starts SoFi with Buy amid 'powerful transition' to 'neo-bank'
SOFI SoFi Technologies
$20.16 /

+0.78 (+4.02%)

SOFI SoFi Technologies
$20.16 /

+0.78 (+4.02%)

SOFI SoFi Technologies
$20.16 /

+0.78 (+4.02%)

SOFI SoFi Technologies
$20.16 /

+0.78 (+4.02%)

Conference/Events
Sensus Healthcare participates in a conference call with Maxim & M-Vest » 10:25
10/18/21
10/18
10:25
10/18/21
10:25
SRTS

Sensus Healthcare

$4.01 /

+0.02 (+0.50%)

Healthcare Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRTS Sensus Healthcare
$4.01 /

+0.02 (+0.50%)

SRTS Sensus Healthcare
$4.01 /

+0.02 (+0.50%)

08/06/21 H.C. Wainwright
Sensus Healthcare price target raised to $7 from $6 at H.C. Wainwright
03/01/21 H.C. Wainwright
Sensus Healthcare price target raised to $6 from $4 at H.C. Wainwright
02/26/21 Northland
Northland upgrades Sensus Healthcare to Outperform after 'strong' Q4 report
02/26/21 Northland
Sensus Healthcare upgraded to Outperform from Market Perform at Northland
SRTS Sensus Healthcare
$4.01 /

+0.02 (+0.50%)

Conference/Events
JPMorgan aerospace/defense analyst holds analyst/industry conference call » 10:25
10/18/21
10/18
10:25
10/18/21
10:25

Aerospace & Defense…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
State Street sees FY21 tax rate toward lower end of 17%-19% range  10:24
10/18/21
10/18
10:24
10/18/21
10:24
STT

State Street

$95.94 /

+3.2 (+3.45%)

 
ShowHide Related Items >><<
STT State Street
$95.94 /

+3.2 (+3.45%)

STT State Street
$95.94 /

+3.2 (+3.45%)

10/07/21 Wolfe Research
State Street upgraded to Outperform from Peer Perform at Wolfe Research
09/24/21 Deutsche Bank
State Street price target lowered to $111 from $120 at Deutsche Bank
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
STT State Street
$95.94 /

+3.2 (+3.45%)

  • 10
    Sep
STT State Street
$95.94 /

+3.2 (+3.45%)

STT State Street
$95.94 /

+3.2 (+3.45%)

STT State Street
$95.94 /

+3.2 (+3.45%)

Hot Stocks
State Street sees Q4 NII $475M-$490M  10:23
10/18/21
10/18
10:23
10/18/21
10:23
STT

State Street

$95.55 /

+2.81 (+3.03%)

 
ShowHide Related Items >><<
STT State Street
$95.55 /

+2.81 (+3.03%)

STT State Street
$95.55 /

+2.81 (+3.03%)

10/07/21 Wolfe Research
State Street upgraded to Outperform from Peer Perform at Wolfe Research
09/24/21 Deutsche Bank
State Street price target lowered to $111 from $120 at Deutsche Bank
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
STT State Street
$95.55 /

+2.81 (+3.03%)

  • 10
    Sep
STT State Street
$95.55 /

+2.81 (+3.03%)

STT State Street
$95.55 /

+2.81 (+3.03%)

STT State Street
$95.55 /

+2.81 (+3.03%)

Hot Stocks
State Street sees FY21 overall fee revenue up 5% y/y » 10:22
10/18/21
10/18
10:22
10/18/21
10:22
STT

State Street

$95.55 /

+2.81 (+3.03%)

Sees servicing fees up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STT State Street
$95.55 /

+2.81 (+3.03%)

STT State Street
$95.55 /

+2.81 (+3.03%)

10/07/21 Wolfe Research
State Street upgraded to Outperform from Peer Perform at Wolfe Research
09/24/21 Deutsche Bank
State Street price target lowered to $111 from $120 at Deutsche Bank
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
STT State Street
$95.55 /

+2.81 (+3.03%)

  • 10
    Sep
STT State Street
$95.55 /

+2.81 (+3.03%)

STT State Street
$95.55 /

+2.81 (+3.03%)

STT State Street
$95.55 /

+2.81 (+3.03%)

Technical Analysis
NASDAQ market internals summary » 10:17
10/18/21
10/18
10:17
10/18/21
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Conference/Events
BTIG healthcare IT/digital health analyst holds analyst/industry conference call » 10:16
10/18/21
10/18
10:16
10/18/21
10:16
SHCR

Sharecare

$6.58 /

-0.26 (-3.80%)

Healthcare IT &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHCR Sharecare
$6.58 /

-0.26 (-3.80%)

SHCR Sharecare
$6.58 /

-0.26 (-3.80%)

09/13/21 BTIG
Sharecare recent selloff creates buying opportunity, says BTIG
08/11/21 BTIG
Sharecare's Q2 results 'excellent,' 'impressive' level of visibility, says BTIG
08/04/21 Canaccord
Sharecare initiated with a Buy at Canaccord
07/28/21 BTIG
Sharecare initiated with a Buy at BTIG
SHCR Sharecare
$6.58 /

-0.26 (-3.80%)

SHCR Sharecare
$6.58 /

-0.26 (-3.80%)

Technical Analysis
NYSE market internals summary » 10:16
10/18/21
10/18
10:16
10/18/21
10:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
International Game put volume heavy and directionally bearish » 10:15
10/18/21
10/18
10:15
10/18/21
10:15
IGT

International Game

$28.86 /

-0.57 (-1.94%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IGT International Game
$28.86 /

-0.57 (-1.94%)

IGT International Game
$28.86 /

-0.57 (-1.94%)

09/09/21 Macquarie
Macquarie says own online gaming into 'major catalyst' of NFL kickoff
07/01/21 Macquarie
Scientific Games divestiture positive for International Game, says Macquarie
05/21/21 Truist
International Game price target raised to $32 from $28 at Truist
05/13/21 Credit Suisse
International Game reinstated with an Outperform at Credit Suisse
IGT International Game
$28.86 /

-0.57 (-1.94%)

IGT International Game
$28.86 /

-0.57 (-1.94%)

IGT International Game
$28.86 /

-0.57 (-1.94%)

General news
U.S. NAHB housing market index climbed 4 ticks to 80 in October » 10:15
10/18/21
10/18
10:15
10/18/21
10:15
$ECON

Economic Data

/

+

U.S. NAHB housing market…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Cantor Fitzgerald biotech analysts to hold an analyst/industry conference call » 10:14
10/18/21
10/18
10:14
10/18/21
10:14
SNY

Sanofi

$48.01 /

-0.83 (-1.70%)

, FOLD

Amicus

$11.13 /

+0.03 (+0.27%)

, ABEO

Abeona Therapeutics

/

+

, QURE

uniQure

$29.24 /

-0.8 (-2.66%)

, SIOX

Sio Gene Therapies

$2.17 /

+ (+0.00%)

, TSHA

Taysha Gene Therapies

$17.48 /

-0.67 (-3.69%)

, SELB

Selecta Biosciences

$4.26 /

-0.01 (-0.23%)

, DNLI

Denali Therapeutics

$45.30 /

-0.27 (-0.59%)

, ORTX

Orchard Therapeutics

$2.11 /

-0.07 (-3.21%)

Biotech Analysts Duncan,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.01 /

-0.83 (-1.70%)

FOLD Amicus
$11.13 /

+0.03 (+0.27%)

ABEO Abeona Therapeutics
/

+

QURE uniQure
$29.24 /

-0.8 (-2.66%)

SIOX Sio Gene Therapies
$2.17 /

+ (+0.00%)

TSHA Taysha Gene Therapies
$17.48 /

-0.67 (-3.69%)

SELB Selecta Biosciences
$4.26 /

-0.01 (-0.23%)

DNLI Denali Therapeutics
$45.30 /

-0.27 (-0.59%)

ORTX Orchard Therapeutics
$2.11 /

-0.07 (-3.21%)

SNY Sanofi
$48.01 /

-0.83 (-1.70%)

10/14/21 JPMorgan
Sanofi price target raised to EUR 105 from EUR 100 at JPMorgan
09/27/21 SVB Leerink
Sanofi upgraded to Outperform at SVB Leerink following pullback
09/27/21 SVB Leerink
Sanofi upgraded to Outperform from Market Perform at SVB Leerink
09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
FOLD Amicus
$11.13 /

+0.03 (+0.27%)

09/30/21
Fly Intel: Top five analyst upgrades
09/30/21 Cowen
Amicus spin-out and profit potential makes it takeout target, says Cowen
09/30/21 JPMorgan
Amicus upgraded to Overweight from Neutral at JPMorgan
07/19/21 BTIG
Amicus assumed with a Buy at BTIG
ABEO Abeona Therapeutics
/

+

07/19/21 H.C. Wainwright
Abeona Therapeutics price target lowered to $5 from $8 at H.C. Wainwright
11/25/20 H.C. Wainwright
Abeona Therapeutics price target lowered to $8 from $11 at H.C. Wainwright
11/11/20 B. Riley Securities
Abeona Therapeutics price target raised to $3 from $2 at B. Riley Securities
11/10/20 Cantor Fitzgerald
Cantor upgrades Abeona to Overweight with shares trading near cash
QURE uniQure
$29.24 /

-0.8 (-2.66%)

07/27/21 Chardan
uniQure price target lowered to $95 from $100 at Chardan
07/09/21 Chardan
uniQure coverage transferred at Chardan
06/23/21 Chardan
uniQure filing delay could yield better label for EtranaDez, says Chardan
06/16/21 Chardan
uniQure on track for 'powerful' Huntington's catalyst, says Chardan
SIOX Sio Gene Therapies
$2.17 /

+ (+0.00%)

07/09/21 Chardan
Sio Gene Therapies coverage transferred at Chardan
06/14/21 BTIG
Sio Gene Therapies initiated with a Buy at BTIG
04/30/21
Fly Intel: Top five analyst initiations
04/30/21 H.C. Wainwright
Sio Gene Therapies initiated with a Buy at H.C. Wainwright
TSHA Taysha Gene Therapies
$17.48 /

-0.67 (-3.69%)

10/05/21 Needham
Taysha Gene Therapies price target raised to $47 from $45 at Needham
08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
SELB Selecta Biosciences
$4.26 /

-0.01 (-0.23%)

07/22/21 Cantor Fitzgerald
Incorrect headline could be cause of Selecta weakness, says Cantor Fitzgerald
06/14/21 BTIG
Selecta Biosciences initiated with a Buy at BTIG
04/29/21 Mizuho
Mizuho sees 'minimal impact' to Selecta Biosciences from AskBio assumption news
03/12/21 William Blair
Selecta upgraded to Outperform ahead of catalysts at William Blair
DNLI Denali Therapeutics
$45.30 /

-0.27 (-0.59%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/01/21 SMBC Nikko
Denali Therapeutics initiated with an Outperform at SMBC Nikko
07/26/21 Stifel
Denali DNL310 data 'noisy and trending in wrong direction,' says Stifel
07/26/21 H.C. Wainwright
Denali Therapeutics price target raised to $105 from $95 at H.C. Wainwright
ORTX Orchard Therapeutics
$2.11 /

-0.07 (-3.21%)

08/18/21 JPMorgan
Orchard Therapeutics downgraded to Neutral from Overweight at JPMorgan
07/02/21 Wedbush
Pharming collaboration offers upside for Orchard Therapeutics, says Wedbush
06/30/21 JPMorgan
Orchard Therapeutics price target lowered to $14 from $15 at JPMorgan
06/30/21 Cantor Fitzgerald
Orchard Therapeutics price target lowered to $12 from $17 at Cantor Fitzgerald
SNY Sanofi
$48.01 /

-0.83 (-1.70%)

FOLD Amicus
$11.13 /

+0.03 (+0.27%)

ABEO Abeona Therapeutics
/

+

QURE uniQure
$29.24 /

-0.8 (-2.66%)

SIOX Sio Gene Therapies
$2.17 /

+ (+0.00%)

TSHA Taysha Gene Therapies
$17.48 /

-0.67 (-3.69%)

SELB Selecta Biosciences
$4.26 /

-0.01 (-0.23%)

DNLI Denali Therapeutics
$45.30 /

-0.27 (-0.59%)

ORTX Orchard Therapeutics
$2.11 /

-0.07 (-3.21%)

SNY Sanofi
$48.01 /

-0.83 (-1.70%)

ORTX Orchard Therapeutics
$2.11 /

-0.07 (-3.21%)

SNY Sanofi
$48.01 /

-0.83 (-1.70%)

FOLD Amicus
$11.13 /

+0.03 (+0.27%)

QURE uniQure
$29.24 /

-0.8 (-2.66%)

TSHA Taysha Gene Therapies
$17.48 /

-0.67 (-3.69%)

DNLI Denali Therapeutics
$45.30 /

-0.27 (-0.59%)

Recommendations
Zillow Group price target lowered to $117 from $174 at Piper Sandler » 10:13
10/18/21
10/18
10:13
10/18/21
10:13
ZG

Zillow Group

$84.41 /

-9.89 (-10.49%)

, Z

Zillow

$84.80 /

-10.14 (-10.68%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZG Zillow Group
$84.41 /

-9.89 (-10.49%)

Z Zillow
$84.80 /

-10.14 (-10.68%)

ZG Zillow Group
$84.41 /

-9.89 (-10.49%)

10/04/21 RBC Capital
Zillow Group price target lowered to $145 from $155 at RBC Capital
09/22/21 Piper Sandler
August home data positive for Zillow and Redfin, says Piper Sandler
09/16/21 BTIG
Zillow Group price target lowered to $145 from $185 at BTIG
08/23/21 Piper Sandler
Home data look positive for Zillow and Redfin, says Piper Sandler
Z Zillow
$84.80 /

-10.14 (-10.68%)

09/22/21 Piper Sandler
August home data positive for Zillow and Redfin, says Piper Sandler
08/09/21 Zelman
Zillow upgraded to Buy from Hold at Zelman
08/06/21 Morgan Stanley
Morgan Stanley trims Zillow price target to $153, sees iBuying re-rating lower
07/21/21 Berenberg
Zillow Group initiated with a Buy at Berenberg
ZG Zillow Group
$84.41 /

-9.89 (-10.49%)

Z Zillow
$84.80 /

-10.14 (-10.68%)

ZG Zillow Group
$84.41 /

-9.89 (-10.49%)

Z Zillow
$84.80 /

-10.14 (-10.68%)

ZG Zillow Group
$84.41 /

-9.89 (-10.49%)

Z Zillow
$84.80 /

-10.14 (-10.68%)

Z Zillow
$84.80 /

-10.14 (-10.68%)

Hot Stocks
State Street expects to reinstate buybacks in 2Q22  10:09
10/18/21
10/18
10:09
10/18/21
10:09
STT

State Street

$96.23 /

+3.49 (+3.76%)

 
ShowHide Related Items >><<
STT State Street
$96.23 /

+3.49 (+3.76%)

STT State Street
$96.23 /

+3.49 (+3.76%)

10/07/21 Wolfe Research
State Street upgraded to Outperform from Peer Perform at Wolfe Research
09/24/21 Deutsche Bank
State Street price target lowered to $111 from $120 at Deutsche Bank
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
STT State Street
$96.23 /

+3.49 (+3.76%)

  • 10
    Sep
STT State Street
$96.23 /

+3.49 (+3.76%)

STT State Street
$96.23 /

+3.49 (+3.76%)

STT State Street
$96.23 /

+3.49 (+3.76%)

Upgrade
Adecoagro upgraded to Overweight on bullish sugar view at Morgan Stanley » 10:06
10/18/21
10/18
10:06
10/18/21
10:06
AGRO

Adecoagro

$9.69 /

+0.755 (+8.45%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGRO Adecoagro
$9.69 /

+0.755 (+8.45%)

AGRO Adecoagro
$9.69 /

+0.755 (+8.45%)

06:20 Today Morgan Stanley
Adecoagro upgraded to Overweight from Equal Weight at Morgan Stanley
03/29/21
Fly Intel: Top five analyst downgrades
03/29/21 Morgan Stanley
Morgan Stanley downgrades Adecoagro, sees limited near-term sugar price upside
03/29/21 Morgan Stanley
Adecoagro downgraded to Equal Weight from Overweight at Morgan Stanley
Hot Stocks
State Street: Acquisition of Brown Brothers Harriman unit financially compelling » 10:05
10/18/21
10/18
10:05
10/18/21
10:05
STT

State Street

$97.10 /

+4.36 (+4.70%)

Comments taken from Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STT State Street
$97.10 /

+4.36 (+4.70%)

STT State Street
$97.10 /

+4.36 (+4.70%)

10/07/21 Wolfe Research
State Street upgraded to Outperform from Peer Perform at Wolfe Research
09/24/21 Deutsche Bank
State Street price target lowered to $111 from $120 at Deutsche Bank
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
STT State Street
$97.10 /

+4.36 (+4.70%)

  • 10
    Sep
STT State Street
$97.10 /

+4.36 (+4.70%)

STT State Street
$97.10 /

+4.36 (+4.70%)

STT State Street
$97.10 /

+4.36 (+4.70%)

Options
Bank of America call volume above normal and directionally bullish » 10:05
10/18/21
10/18
10:05
10/18/21
10:05
BAC

Bank of America

$46.80 /

+0.43 (+0.93%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BAC Bank of America
$46.80 /

+0.43 (+0.93%)

BAC Bank of America
$46.80 /

+0.43 (+0.93%)

10/15/21 Evercore ISI
Bank of America price target raised to $48 from $43 at Evercore ISI
10/15/21 RBC Capital
Bank of America price target raised to $50 from $44 at RBC Capital
10/15/21 Oppenheimer
Bank of America price target raised to $51 from $48 at Oppenheimer
10/15/21 Barclays
Bank of America price target raised to $49 from $45 at Barclays
BAC Bank of America
$46.80 /

+0.43 (+0.93%)

BAC Bank of America
$46.80 /

+0.43 (+0.93%)

BAC Bank of America
$46.80 /

+0.43 (+0.93%)

BAC Bank of America
$46.80 /

+0.43 (+0.93%)

General news
U.S. industrial production sharply undershot estimates » 10:05
10/18/21
10/18
10:05
10/18/21
10:05
$ECON

Economic Data

/

+

U.S. industrial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Taysha Gene Therapies management to meet with Needham » 10:04
10/18/21
10/18
10:04
10/18/21
10:04
TSHA

Taysha Gene Therapies

$17.82 /

-0.33 (-1.82%)

Meeting to be held in the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$17.82 /

-0.33 (-1.82%)

TSHA Taysha Gene Therapies
$17.82 /

-0.33 (-1.82%)

10/05/21 Needham
Taysha Gene Therapies price target raised to $47 from $45 at Needham
08/17/21 Chardan
Taysha Gene Therapies price target lowered to $60 from $67.50 at Chardan
07/15/21 Needham
Taysha Gene Therapies initiated with a Buy at Needham
07/09/21 Chardan
Taysha Gene Therapies coverage transferred at Chardan
TSHA Taysha Gene Therapies
$17.82 /

-0.33 (-1.82%)

TSHA Taysha Gene Therapies
$17.82 /

-0.33 (-1.82%)

Hot Stocks
Interactive Brokers introduces cryptocurrency trading for financial advisors » 10:01
10/18/21
10/18
10:01
10/18/21
10:01
IBKR

Interactive Brokers

$70.77 /

-0.32 (-0.45%)

, $BTC

Bitcoin

/

+

, $ETH

Ethereum

/

+

, $LTC

Litecoin

/

+

, $BCH

Bitcoin Cash

/

+

Interactive Brokers Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBKR Interactive Brokers
$70.77 /

-0.32 (-0.45%)

$BTC Bitcoin
/

+

$ETH Ethereum
/

+

$LTC Litecoin
/

+

$BCH Bitcoin Cash
/

+

IBKR Interactive Brokers
$70.77 /

-0.32 (-0.45%)

04/21/21 Credit Suisse
Interactive Brokers price target raised to $110 from $92 at Credit Suisse
04/09/21 Jefferies
Charles Schwab price target raised to $76 from $70 at Jefferies
04/05/21 Goldman Sachs
Interactive Brokers price target raised to $83 from $73 at Goldman Sachs
03/05/21 Jefferies
Interactive Brokers initiated with a Buy at Jefferies
$BTC Bitcoin
/

+

09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
$ETH Ethereum
/

+

05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
05/07/21 Argus
Ethan Allen upgraded to Buy from Hold at Argus
11/24/20 UBS
RH price target raised to $450 from $380 at UBS
$LTC Litecoin
/

+

06/03/21 Mizuho
LTC Properties downgraded to Underperform from Neutral at Mizuho
03/30/21 Capital One
LTC Properties downgraded to Equalweight from Overweight at Capital One
03/03/21 RBC Capital
LTC Properties price target raised to $38 from $33 at RBC Capital
02/09/21 Mizuho
LTC Properties price target raised to $38 from $35 at Mizuho
$BCH Bitcoin Cash
/

+

03/26/21 Credit Suisse
Banco de Chile downgraded to Neutral from Outperform at Credit Suisse
11/17/20 Itau BBA
Banco de Chile upgraded to Outperform from Market Perform at Itau BBA
IBKR Interactive Brokers
$70.77 /

-0.32 (-0.45%)

$BTC Bitcoin
/

+

$ETH Ethereum
/

+

$LTC Litecoin
/

+

IBKR Interactive Brokers
$70.77 /

-0.32 (-0.45%)

$BTC Bitcoin
/

+

$ETH Ethereum
/

+

$LTC Litecoin
/

+

IBKR Interactive Brokers
$70.77 /

-0.32 (-0.45%)

$BTC Bitcoin
/

+

$ETH Ethereum
/

+

$LTC Litecoin
/

+

$ETH Ethereum
/

+

Hot Stocks
Atlantic Capital, Self expand partnership to improve financial inclusion » 10:00
10/18/21
10/18
10:00
10/18/21
10:00
ACBI

Atlantic Capital

$27.40 /

-0.2 (-0.72%)

Atlantic Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACBI Atlantic Capital
$27.40 /

-0.2 (-0.72%)

ACBI Atlantic Capital
$27.40 /

-0.2 (-0.72%)

09/21/21 DA Davidson
South State upgraded to Buy at DA Davidson after relative underperformance
07/27/21 Truist
South State price target lowered to $90 from $100 at Truist
07/27/21 Piper Sandler
Atlantic Capital downgraded to Neutral from Overweight at Piper Sandler
07/26/21 Truist
Atlantic Capital price target lowered to $26.50 from $32 at Truist
ACBI Atlantic Capital
$27.40 /

-0.2 (-0.72%)

Hot Stocks
Medtronic falls -5.9% » 10:00
10/18/21
10/18
10:00
10/18/21
10:00
MDT

Medtronic

$120.32 /

-7.33 (-5.74%)

Medtronic is down -5.9%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MDT Medtronic
$120.32 /

-7.33 (-5.74%)

MDT Medtronic
$120.32 /

-7.33 (-5.74%)

08:49 Today Morgan Stanley
Medtronic bias positive at Morgan Stanley despite 'not optimal' ON MED update
08:19 Today Wells Fargo
Medtronic price target lowered to $144 from $151 at Wells Fargo
04:55 Today Piper Sandler
Medtronic growth pathway now 'a little riskier,' says Piper Sandler
09/14/21 Piper Sandler
CMS full repeal proposal of MCIT negative for med tech, says Piper Sandler
MDT Medtronic
$120.32 /

-7.33 (-5.74%)

MDT Medtronic
$120.32 /

-7.33 (-5.74%)

MDT Medtronic
$120.32 /

-7.33 (-5.74%)

MDT Medtronic
$120.32 /

-7.33 (-5.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.